Skip to content
HealthcareRisk Manager

ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients for Risk Managers

What does ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients require of a Risk Manager?

ICH Q7, the international GMP guideline for active pharmaceutical ingredients: the independent quality unit and batch release, personnel, facilities and equipment, computerised systems, documentation and batch records, materials and supplier qualification, production and in-process controls, labelling, storage and distribution, laboratory controls, stability and reserve samples, validation, change control, rework, complaints and recalls, contract manufacturers, distributors and brokers, biotech APIs and clinical trial APIs. Under ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, which defines 71 controls, a Risk Manager's work is deciding which controls you own outright, which you share and which belong to another team, then holding the evidence for the first group.

Which ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients controls land on the Risk Manager

Risk Managers identify, assess, and prioritise organisational risks. They build risk registers, conduct risk assessments, define risk appetite, and ensure that compliance frameworks address the most material threats to the organisation.

ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients defines 71 controls across 9 domains that directly affect the Risk Manager role. Understanding which controls fall within your ownership, which are shared, and which are owned by other teams is the foundation of effective compliance management.

What a Risk Manager is accountable for under ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

1

Conducting enterprise risk assessments and maintaining the risk register

2

Defining risk appetite and tolerance levels with executive leadership

3

Mapping compliance controls to identified risks for coverage analysis

4

Monitoring key risk indicators (KRIs) and escalating emerging threats

5

Integrating compliance, operational, and strategic risk management

Where Risk Managers lose time on ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

These are the most common obstacles Risk Managers face when managing ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients compliance, and how to address them:

Challenge 1

Quantifying cyber risk in financial terms that resonate with executives

Challenge 2

Identifying gaps between compliance control coverage and actual risk exposure

Challenge 3

Integrating risk data from siloed tools and departments

Challenge 4

Keeping risk assessments current as the threat landscape evolves

Challenge 5

Prioritising remediation when resources are limited

A working order for a Risk Manager starting on ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

1. Readiness Assessment

Take a 5-minute readiness assessment to identify your organisation's current gap profile against ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Get a prioritised action plan tailored to your specific situation.

2. Cross-Framework Mapping

Use our platform to map ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients controls against other frameworks you already comply with. Identify overlapping controls to reduce duplicate effort.

3. Build Your Toolkit

Equip yourself with ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients toolkits, self-assessments, and implementation guides from our store. Resources designed specifically for Risk Managers managing compliance programmes.

4. Continuous Monitoring

Establish ongoing compliance monitoring using our platform's gap analysis tools. Track your maturity over time and demonstrate progress to stakeholders.

ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients in your sector

Who else owns part of ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

Questions Risk Managers ask about ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

What does a Risk Manager need to know about ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients?
As a Risk Manager, your key responsibilities under ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients include conducting enterprise risk assessments and maintaining the risk register and defining risk appetite and tolerance levels with executive leadership. The framework contains 71 controls that fall within your area of responsibility. Understanding which controls you own versus which are shared with other teams is critical for effective implementation.
How does ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients affect the Risk Manager role?
ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients directly impacts Risk Managers through conducting enterprise risk assessments and maintaining the risk register, defining risk appetite and tolerance levels with executive leadership, mapping compliance controls to identified risks for coverage analysis. The framework provides structure that helps Risk Managers demonstrate due diligence and report compliance status to stakeholders.
What are the biggest ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients challenges for Risk Managers?
Common challenges include quantifying cyber risk in financial terms that resonate with executives; identifying gaps between compliance control coverage and actual risk exposure; integrating risk data from siloed tools and departments. Using cross-framework mapping tools and automated evidence collection can significantly reduce these pain points.
How should a Risk Manager prepare for a ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients audit?
Start by conducting a readiness assessment to identify gaps. Then focus on mapping compliance controls to identified risks for coverage analysis and monitoring key risk indicators (kris) and escalating emerging threats. Maintain a current evidence repository and ensure all control owners have documented their processes. Our readiness reports provide a prioritised action plan specific to your gap profile.
What tools help Risk Managers manage ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients compliance?
Effective ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients compliance management requires tools for gap analysis, control mapping, evidence collection, and reporting. Our compliance platform provides AI-powered gap analysis across 1,111 frameworks with 315K+ verified control-to-control mappings, helping Risk Managers identify overlapping requirements and reduce duplicate compliance effort.

Risk Manager: How ready is your organisation for ICH Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients?

Answer 25 questions and get a professional readiness report with gap analysis, maturity scores, and prioritised action items. Results in 5 minutes.

Written and maintained by Gerard Blokdyk, The Art of Service.Last updated .